Post COVID Condition
8
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Micro-choice-based Intervention for Multicausal Fatigue
SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition
Sonlicromanol in Post-COVID
RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
RECLAIM Adaptive Platform Trial for PCC Treatments
Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19
Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome
Vagus Stimulation in Female Long COVID Patients.